Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Immune cells are crucial for hair growth and preventing hair loss.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

A woman with severe hair loss was successfully treated with the drug adalimumab.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.